Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew M Grabowski

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
JCI Insight|October 11, 2019
Metronomic capecitabine as an immune modulator in glioblastoma patients reduces myeloid-derived suppressor cellsDavid M Peereboom, Tyler J Alban, Matthew M Grabowski, et al.
Neuro-Oncology Advances|April 25, 2025
Expedited chemoradiation after laser interstitial thermal therapy (LITT) is feasible and safe in patients with newly diagnosed glioblastomaJennifer S Yu, Seth M Meade, Ran Zhao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 5, 2021
Preclinical Modeling of Surgery and Steroid Therapy for Glioblastoma Reveals Changes in Immunophenotype that are Associated with Tumor Growth and OutcomeBalint Otvos, Tyler J Alban, Matthew M Grabowski, et al.
Journal of Neuro-Oncology|December 23, 2025
The impact of the molecular and genetic properties of glioblastoma on patient outcomes following stereotactic radiosurgery at recurrenceJohnathon W Evers Smith, Juan D Alzate, Landon Power, et al.
Neuro-Oncology Advances|July 7, 2022
Combination laser interstitial thermal therapy plus stereotactic radiotherapy increases time to progression for biopsy-proven recurrent brain metastasesMatthew M Grabowski, Ethan S Srinivasan, Eugene J Vaios, et al.
JCI Insight|November 3, 2018
Global immune fingerprinting in glioblastoma patient peripheral blood reveals immune-suppression signatures associated with prognosisTyler J Alban, Alvaro G Alvarado, Mia D Sorensen, et al.
Cancer Discovery|June 28, 2023
Sex-Biased T-cell Exhaustion Drives Differential Immune Responses in GlioblastomaJuyeun Lee, Michael Nicosia, Ellen S Hong, et al.
Cancer Discovery|April 18, 2020
Myeloid-Derived Suppressor Cell Subsets Drive Glioblastoma Growth in a Sex-Specific MannerDefne Bayik, Yadi Zhou, Chihyun Park, et al.
Biorxiv : the Preprint Server for Biology|November 28, 2023
Tumor cell-derived spermidine promotes a pro-tumorigenic immune microenvironment in glioblastoma via CD8+ T cell inhibitionKristen E Kay, Juyeun Lee, Ellen S Hong, et al.
The Journal of Clinical Investigation|November 19, 2024
Tumor cell-derived spermidine promotes a protumorigenic immune microenvironment in glioblastoma via CD8+ T cell inhibitionKristen E Kay, Juyeun Lee, Ellen S Hong, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
JCI Insight|October 11, 2019
Metronomic capecitabine as an immune modulator in glioblastoma patients reduces myeloid-derived suppressor cellsDavid M Peereboom, Tyler J Alban, Matthew M Grabowski, et al.
Neuro-Oncology Advances|April 25, 2025
Expedited chemoradiation after laser interstitial thermal therapy (LITT) is feasible and safe in patients with newly diagnosed glioblastomaJennifer S Yu, Seth M Meade, Ran Zhao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 5, 2021
Preclinical Modeling of Surgery and Steroid Therapy for Glioblastoma Reveals Changes in Immunophenotype that are Associated with Tumor Growth and OutcomeBalint Otvos, Tyler J Alban, Matthew M Grabowski, et al.
Journal of Neuro-Oncology|December 23, 2025
The impact of the molecular and genetic properties of glioblastoma on patient outcomes following stereotactic radiosurgery at recurrenceJohnathon W Evers Smith, Juan D Alzate, Landon Power, et al.
Neuro-Oncology Advances|July 7, 2022
Combination laser interstitial thermal therapy plus stereotactic radiotherapy increases time to progression for biopsy-proven recurrent brain metastasesMatthew M Grabowski, Ethan S Srinivasan, Eugene J Vaios, et al.
JCI Insight|November 3, 2018
Global immune fingerprinting in glioblastoma patient peripheral blood reveals immune-suppression signatures associated with prognosisTyler J Alban, Alvaro G Alvarado, Mia D Sorensen, et al.
Cancer Discovery|June 28, 2023
Sex-Biased T-cell Exhaustion Drives Differential Immune Responses in GlioblastomaJuyeun Lee, Michael Nicosia, Ellen S Hong, et al.
Cancer Discovery|April 18, 2020
Myeloid-Derived Suppressor Cell Subsets Drive Glioblastoma Growth in a Sex-Specific MannerDefne Bayik, Yadi Zhou, Chihyun Park, et al.
Biorxiv : the Preprint Server for Biology|November 28, 2023
Tumor cell-derived spermidine promotes a pro-tumorigenic immune microenvironment in glioblastoma via CD8+ T cell inhibitionKristen E Kay, Juyeun Lee, Ellen S Hong, et al.
The Journal of Clinical Investigation|November 19, 2024
Tumor cell-derived spermidine promotes a protumorigenic immune microenvironment in glioblastoma via CD8+ T cell inhibitionKristen E Kay, Juyeun Lee, Ellen S Hong, et al.
Pageof 4